🔊CEOInterviews

Marcia Eisenberg on testing access

From LabCorp's Marcia Eisenberg on new testing for coronavirus patients · · CNBCTelevision

“Right — they can't walk into a LabCorp patient center and do it there.”

Marcia Eisenberg
Chief Scientific Officer & Senior Vice President, Laboratory Corporation of Amerc Holdings
Controversial testing accesspatient logistics

On , Marcia Eisenberg, Chief Scientific Officer & Senior Vice President at Laboratory Corporation of Amerc Holdings, spoke about testing access during LabCorp's Marcia Eisenberg on new testing for coronavirus patients on CNBCTelevision.

LabCorp's Marcia Eisenberg on new testing for coronavirus patients
Watch on YouTube
LabCorp's Marcia Eisenberg on new testing for coronavirus patients
CNBCTelevision
Watch on YouTube
Marcia Eisenberg, chief scientific officer at LabCorp, joins "Squawk on the Street" to discuss the company's new test for coronavirus that is available to doctors nationwide. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://www.cnbc.com/pro/?__source=yo... » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. Connect with CNBC News Online Get the latest news: http://www.cnbc.com/ Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC #CNBC #CNBC TV
Marcia Eisenberg

About Marcia Eisenberg

Chief Scientific Officer & Senior Vice President · Laboratory Corporation of Amerc Holdings

In March 2020, Marcia Eisenberg, chief scientific officer and senior vice president at Labcorp, discussed the company's new test for the coronavirus on CNBC's "Squawk on the Street." She stated that Labcorp began receiving samples on the Thursday prior to the interview and had begun reporting results. Eisenberg said the company had capacity for "several thousand a day" and was working "almost around the clock" to increase that capacity over the following weeks. Eisenberg explained that samples—oral and nasal swabs—must be collected at a physician's office, not at a Labcorp patient center. She noted that as a national provider, Labcorp could receive samples from all states, regardless of geographic hot spots. She described the turnaround time as "up to three to four days" and said the company was still awaiting final pricing from the Centers for Medicare & Medicaid Services (CMS) and the American Medical Association (AMA).

Profile compiled from Marcia Eisenberg's verified public interviews and appearances. See all quotes & transcripts →

More from Marcia Eisenberg LabCorp (LH) Full Transcript Explore All Executives